These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16861241)

  • 1. Nephrotoxicity of vancomycin in patients with normal serum creatinine.
    Colares VS; Oliveira RB; Abdulkader RC
    Nephrol Dial Transplant; 2006 Dec; 21(12):3608. PubMed ID: 16861241
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of vancomycin-associated nephrotoxicity.
    Moh'd H; Kheir F; Kong L; Du P; Farag H; Mohamad A; Zurlo JJ
    South Med J; 2014 Jun; 107(6):383-8. PubMed ID: 24945176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
    Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
    Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
    Pritchard L; Baker C; Leggett J; Sehdev P; Brown A; Bayley KB
    Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
    Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA
    J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A; Mergenhagen KA; Mattappallil A
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.
    Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH
    Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
    Malacarne P; Bergamasco S; Donadio C
    Chemotherapy; 2006; 52(4):178-84. PubMed ID: 16691027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.
    McKamy S; Hernandez E; Jahng M; Moriwaki T; Deveikis A; Le J
    J Pediatr; 2011 Mar; 158(3):422-6. PubMed ID: 20888013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors.
    Meaney CJ; Hynicka LM; Tsoukleris MG
    Pharmacotherapy; 2014 Jul; 34(7):653-61. PubMed ID: 24700598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular disorders in low birth weight neonates after prolonged antibiotic treatment.
    Giapros VI; Papadimitriou FK; Andronikou SK
    Neonatology; 2007; 91(2):140-4. PubMed ID: 17344665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between vancomycin-associated nephrotoxicity and the number of combined nephrotoxic agents.
    Ueki T; Sanematsu E; Furuya Y; Shinohara Y; Murakami Y; Miyazaki A; Sakamoto Y; Nakashima MN; Nakashima M
    Pharmazie; 2020 Jun; 75(6):279-283. PubMed ID: 32539926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glycopeptides and the newborn infant's kidney].
    Fanos V; Benini D; Vinco S; Pizzini C; Khoory BJ
    Pediatr Med Chir; 1997; 19(4):259-62. PubMed ID: 9508651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity associated with vancomycin-aminoglycoside therapy in four children.
    Odio C; McCracken GH; Nelson JD
    J Pediatr; 1984 Sep; 105(3):491-3. PubMed ID: 6470874
    [No Abstract]   [Full Text] [Related]  

  • 17. An unusual case of acute kidney injury due to vancomycin lessons learnt from reliance on eGFR.
    Barraclough K; Harris M; Montessori V; Levin A
    Nephrol Dial Transplant; 2007 Aug; 22(8):2391-4. PubMed ID: 17470454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
    Barberan J; Mensa J; Artero A; Epelde F; Rodriguez JC; Ruiz-Morales J; Calleja JL; Guerra JM; Martínez-Gil I; Giménez MJ; Granizo JJ; Aguilar L
    Rev Esp Quimioter; 2019 Feb; 32(1):22-30. PubMed ID: 30630306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of a decision tree model for the analysis of adverse drug reactions: Evaluation of a risk prediction model of vancomycin-associated nephrotoxicity constructed using a data mining procedure.
    Imai S; Yamada T; Kasashi K; Kobayashi M; Iseki K
    J Eval Clin Pract; 2017 Dec; 23(6):1240-1246. PubMed ID: 28544476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
    Nahata MC
    Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.